Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway

The failure of lung cancer treatments has been attributed mostly to the development of drug resistance, however the underlying cellular and molecular mechanisms are poorly understood. Cancer initiating stem cells (CSCs), present in tumors in a small percentage, play critical roles in the development...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Green, Ryan, Howell, Mark, Khalil, Roukiah, Nair, Rajesh, Yan, Jiyu, Foran, Elspeth, Katiri, Sandhyabanu, Banerjee, Jit, Singh, Mandip, Bharadwaj, Srinivas, Mohapatra, Shyam S., Mohapatra, Subhra
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6890794/
https://ncbi.nlm.nih.gov/pubmed/31796785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-54266-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak